Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Quarterly sales volumes averaged 355 MBoe/d, up 10 MBoe/d from the midpoint of the Company’s original guidance range, on capital expenditures of $633 million which were toward the lower end of...
-
ST. PAUL, Minn., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Regions Hospital, Orthopaedic Trauma department, is the first Level 1 Academic Trauma center to invest in the infrastructure to scale their...
-
Poster featured at 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsCompany anticipates filing an IND for FPT155 in mid 2018 SOUTH SAN FRANCISCO, Calif., Oct. ...
-
JACKSONVILLE, Fla., Oct. 25, 2017 (GLOBE NEWSWIRE) -- ParkerVision, Inc. (Nasdaq:PRKR) (“ParkerVision” or “Company”), a developer and marketer of semiconductor technology solutions for wireless...
-
Five Prime Therapeutics Announces Appointment of Aron Knickerbocker as CEO Effective January 1, 2018
SOUTH SAN FRANCISCO, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative...
-
QUÉBEC, QUÉBEC--(Marketwired - 23 oct. 2017) - Les Ressources Komet Inc. (« Komet » ou la « Société ») (TSX CROISSANCE:KMT) est heureuse de faire le...
-
WASHINGTON, D.C., Oct. 19, 2017 (GLOBE NEWSWIRE) -- The American Veterans Center’s annual holiday television special, American Valor: A Salute to Our Heroes, will return to television this Fall for...
-
Dublin, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The "Footwear - Global Strategic Business Report" report has been added to Research and Markets' offering. The report provides separate...
-
SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative...
-
Arix Bioscience notes Harpoon Therapeutics' immuno-oncology collaboration with AbbVie LONDON, 18 October 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience"), a global healthcare and life...